Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04270604 · ClinicalTrials.gov registry record
Biological Sample Collection for Research and Biobanking
A clinical trial, sponsored by New York Stem Cell Foundation Research Institute.
- Terminated
- Registry status
- 1,279
- Enrollment target
NCT04270604: Clinical Trial study, sponsored by New York Stem Cell Foundation Research Institute.
NCT04270604 is a clinical trial that was terminated before completion, run by New York Stem Cell Foundation Research Institute. The registered enrollment target is 1,279 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04270604 was terminated before completion, sponsored by New York Stem Cell Foundation Research Institute.
- TERMINATED
- Registry status
- 1,279 participants
- Enrollment target
Study Summary
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to study different conditions and diseases by using cells from the body (such as skin or blood cells). NYSCF uses these samples to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store these samples for future use. Through this research, scientists hope to identify future treatments or even cures.
Primary Outcome
There are no primary endpoints planned for this biobank; endpoints will be specific to research projects that utilize samples/data contained in the biobank. Projects may investigate the biology, etiology, manifestations, progression, risk factors, genetic underpinnings, and treatment of diseases, conditions, and traits.
Interventions
- OTHER Biological sample collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,279 participants |
| Start Date | 2012-02-06 |
| Est. Completion | 2023-11-27 |
Why NCT04270604 stopped before completion
NCT04270604 is an observational study that tracks outcomes without assigning an intervention. Its 1,279 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Biological sample collection is the first listed.
NCT04270604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04270604 about?
NCT04270604 is a clinical study titled "Biological Sample Collection for Research and Biobanking". The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to study different conditions and diseases by using cells from the body (such as skin or blood cells). NYSCF uses these samples to make stem cells and other types of cells, conduct research on the samples, perfo...
What is the current status of trial NCT04270604?
This trial is currently terminated. The enrollment target is 1,279 participants. The study started on 2012-02-06. Estimated completion is 2023-11-27.
What interventions are being tested in trial NCT04270604?
The interventions under investigation include: Biological sample collection (OTHER).
Who is sponsoring clinical trial NCT04270604?
This trial is sponsored by New York Stem Cell Foundation Research Institute, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI